HY2Care Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
12

- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Latest Deal Amount
-
$4.67M
- Investors
-
7
HY2Care General Information
Description
Manufacturer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel are composed of a mixture of natural polymer conjugates that cross-link in a mild enzymatic reaction, enabling clinicians to treat patients with functional repair of cartilage defects in the knee.
Contact Information
Website
www.hy2care.comCorporate Office
- Urmonderbaan 22
- 6167 RD Geleen
- Netherlands
Corporate Office
- Urmonderbaan 22
- 6167 RD Geleen
- Netherlands
HY2Care Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Later Stage VC | 27-Jan-2025 | $4.67M | In Progress | Generating Revenue | ||
7. Grant | 23-Mar-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series A) | 30-Apr-2019 | Completed | Generating Revenue | |||
5. Angel (individual) | 01-Jan-2017 | Completed | Generating Revenue | |||
4. Grant | 04-Aug-2016 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | Completed | Generating Revenue | ||||
2. Accelerator/Incubator | 13-Apr-2015 | $16.2K | $16.2K | Completed | Generating Revenue | |
1. Grant | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
HY2Care Patents
HY2Care Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4403195-A1 | Kit of parts suitable for preparing a biocompatible polymeric hydrogel | Pending | 17-Jan-2023 | ||
CA-3088978-A1 | Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules | Pending | 18-Jan-2018 | ||
EP-3740525-A1 | Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules | Active | 18-Jan-2018 | ||
US-11414483-B2 | Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules | Active | 18-Jan-2018 | ||
US-20200347125-A1 | Porous affinity hydrogel particles for reducing the bioavailability of selected biological molecules | Active | 18-Jan-2018 | C08J3/075 |
HY2Care Signals
HY2Care Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
European Innovation Council Fund | Venture Capital | Minority | ||
Brightlands Venture Partners | Venture Capital | Minority | ||
ReumaNederland | Corporation | Minority | ||
Horizon 2020 SME Instrument | Government | |||
Startupbootcamp | VC-Backed Company | Minority |
HY2Care FAQs
-
When was HY2Care founded?
HY2Care was founded in 2014.
-
Where is HY2Care headquartered?
HY2Care is headquartered in Geleen, Netherlands.
-
What is the size of HY2Care?
HY2Care has 12 total employees.
-
What industry is HY2Care in?
HY2Care’s primary industry is Other Devices and Supplies.
-
Is HY2Care a private or public company?
HY2Care is a Private company.
-
What is HY2Care’s current revenue?
The current revenue for HY2Care is
. -
How much funding has HY2Care raised over time?
HY2Care has raised $8.84M.
-
Who are HY2Care’s investors?
European Innovation Council Fund, Brightlands Venture Partners, ReumaNederland, Horizon 2020 SME Instrument, and Startupbootcamp are 5 of 7 investors who have invested in HY2Care.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »